Subject: Teva Baltics pöördumine
From: "Kristina Glinjanskaja" <[email-masked]>
To: <[email-masked]>
Cc: <[email-masked]>, "RAM Info", <[email-masked]>
Date: Thu, 19 Sep 2024 13:20:35 +0300

Tere

Pöördume teie poole seoses asulareovee puhastamise direktiivi (UWWTD) ning 
selle negatiivse mõjuga kriitiliste ravimite kättesaadavusele Eestis.

Parimate soovidega

Kristina Glinjanskaja
Key account manager

Cell:  <tel:+372-57501116> +372-57501116

 <mailto:[email-masked]> [email-masked] 
<http://www.tevapharm.com/> www.tevapharm.com

This message is intended solely for the designated recipient(s). It may 
contain confidential or proprietary information and may be subject to 
attorney-client privilege or other confidentiality protections. If you are 
not a designated recipient you may not review, copy or distribute this 
message. If you receive this in error, please notify the sender by reply 
e-mail and delete this message. Thank you.